Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
6
NCT04390152
Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 13, 2020
Completion: Mar 3, 2022